To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene DIS3L2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
213 supporting clones for gene DIS3L2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BX646318   .a 1 to 562 1 to 562   tiling clone,   562/562
(100 %)
2 diff
(99.7 %id)
NM_152383.4   .a 340 to 3846 1 to 3507 exact RefSeq,   3507/3507
(100 %)
4 diff
(99.9 %id)
BF979456 testis .a 436 to 990 1 to 555       555/1110
(50 %)
12 diff
(99.0 %id)
BX377429 Placenta Cot 25-normalized .a 522 to 1380 1 to 859   tiling clone,   859/859
(100 %)
0 diff
(100 %id)
CR985006 T-Lymphocytes .a 1711 to 2472 1 to 763   tiling clone,   763/763
(100 %)
1 diff
(99.9 %id)
BF204262 muscle, rhabdomyosarcoma .a 1799 to 2355 1 to 553       553/693
(79 %)
7 diff
(99.0 %id)
BF304859 muscle, rhabdomyosarcoma .a 1799 to 2543 1 to 734       734/887
(82 %)
32 diff
(96.4 %id)
BG825206 muscle, rhabdomyosarcoma .a 1799 to 2533 1 to 735       735/735
(100 %)
2 diff
(99.8 %id)
BI114256 muscle, rhabdomyosarcoma .a 1799 to 2520 1 to 723       723/825
(87 %)
22 diff
(97.4 %id)
DR156743 human embryonic stem cells differentiated toan early endodermal cell type .a 1813 to 2661 1 to 848       848/848
(100 %)
6 diff
(99.3 %id)
CD251979 testis .a 1832 to 2722 1 to 897       897/897
(100 %)
13 diff
(98.6 %id)
BG750784 eye, normal pigmented retinal epithelium .a 1837 to 2543 1 to 703       703/711
(98 %)
11 diff
(98.5 %id)
CB268980 adipose .a 1896 to 2562 1 to 668       667/671
(99 %)
11 diff
(98.4 %id)
BM012844 brain, neuroblastoma, cell line .a 1963 to 2841 1 to 874       874/961
(90 %)
24 diff
(97.6 %id)
TI_59382074   .a 1963 to 2841 99 to 972       874/961
(90 %)
24 diff
(97.6 %id)
BE545087 cervical carcinoma cell line, cervix .a 2122 to 2821 1 to 693       693/697
(99 %)
12 diff
(98.3 %id)
BG746662 adenocarcinoma cell line, colon .a 2133 to 2859 1 to 727   tiling clone,   727/727
(100 %)
0 diff
(100 %id)
BM817794 stomach .a 2162 to 2750 1 to 588       588/588
(100 %)
1 diff
(99.9 %id)
BQ320364 colon .a 2243 to 2458 8 to 220       213/241
(88 %)
9 diff
(96.3 %id)
BQ320492 colon .a 2274 to 2457 1 to 183       183/197
(92 %)
8 diff
(96.0 %id)
BG877875 leiomios .a 2315 to 2794 12 to 491       480/491
(97 %)
8 diff
(98.4 %id)
BX377428 Placenta Cot 25-normalized .a 2672 to 3592 917 to 5       913/917
(99 %)
6 diff
(99.4 %id)
BG706389 brain, hypothalamus .a 2756 to 3619 1 to 858   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 858/858
(100 %)
30 diff
(96.6 %id)
BG716230 brain, hypothalamus .a 2756 to 3603 1 to 848   available from MGC,   848/849
(99 %)
27 diff
(96.9 %id)
BC030113 Brain, hypothalamus .a 2761 to 3619 1 to 859   available from MGC, AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 859/859
(100 %)
4 diff
(99.6 %id)
BF980184 testis .a 2781 to 3555 783 to 10       774/887
(87 %)
4 diff
(99.6 %id)
CB047320 Kidney .a 2798 to 3409 1 to 612   tiling clone, fully sequenced,   612/612
(100 %)
4 diff
(99.4 %id)
BM040906 Kidney, Wilms' tumor, cell line .a 2804 to 3282 1 to 479   fully sequenced,   479/479
(100 %)
1 diff
(99.8 %id)
DW009918 pooled .a 2893 to 3116 1 to 224       224/261
(85 %)
6 diff
(97.8 %id)
CN390908 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2915 to 3439 1 to 524       524/524
(100 %)
1 diff
(99.9 %id)
BX094404 breast .a 2951 to 3619 1 to 670   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 670/670
(100 %)
2 diff
(99.8 %id)
R73057 breast .a 2951 to 3286 1 to 339   fully sequenced,   339/339
(100 %)
5 diff
(98.6 %id)
CN390905 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 3041 to 3619 1 to 579   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 579/579
(100 %)
0 diff
(100 %id)
TI_149275130   .a 3050 to 3619 668 to 95   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 574/726
(79 %)
17 diff
(97.7 %id)
TI_149283627   .a 3050 to 3619 653 to 83   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 571/1080
(52 %)
1 diff
(100.0 %id)
BU680248 lung, Primary Lung Epithelial Cells .a 3050 to 3619 589 to 19   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 571/579
(98 %)
1 diff
(99.9 %id)
CA426685 cell lines, Chondrosarcoma .a 3082 to 3619 557 to 19   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 539/539
(100 %)
22 diff
(96.0 %id)
BQ581372 insulinoma, Pancreas .a 3087 to 3563 1 to 477       477/477
(100 %)
4 diff
(99.2 %id)
DB577662 hypothalamus .a 3125 to 3619 1 to 495     Submitted on the opposite strand 495/495
(100 %)
2 diff
(99.6 %id)
BX416168 neuroblastoma .a 3135 to 3841 1 to 707   tiling clone,   707/707
(100 %)
2 diff
(99.8 %id)
BX395243 Neuroblastoma Cot 50-normalized .a 3161 to 3620 1 to 460       460/460
(100 %)
3 diff
(99.4 %id)
DB553956 hypothalamus .a 3169 to 3619 1 to 447     Submitted on the opposite strand 447/447
(100 %)
29 diff
(93.6 %id)
AW771610 Kidney .a 3186 to 3620 444 to 10       435/444
(97 %)
0 diff
(100 %id)
DB561799 hypothalamus .a 3193 to 3619 1 to 428     Submitted on the opposite strand 428/428
(100 %)
18 diff
(95.8 %id)
BU676569 lung, Primary Lung Epithelial Cells .a 3220 to 3619 420 to 19   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 402/402
(100 %)
3 diff
(99.3 %id)
CB047065 2 pooled tumors (clear cell type), Kidney .a 3230 to 3619 1 to 390   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 390/390
(100 %)
4 diff
(99.0 %id)
BM041801 Kidney, Wilms' tumor, cell line .a 3252 to 3569 322 to 1   fully sequenced,   322/322
(100 %)
9 diff
(97.3 %id)
R73058 breast .a 3256 to 3590 338 to 1   fully sequenced,   338/338
(100 %)
4 diff
(98.9 %id)
BF509193   .a 3263 to 3619 376 to 18   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 359/361
(99 %)
8 diff
(97.8 %id)
BF175394 blood .a 3265 to 3573 1 to 302       302/302
(100 %)
12 diff
(96.1 %id)
AI493578 adenocarcinoma, Pancreas .a 3289 to 3619 342 to 12   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 331/331
(100 %)
0 diff
(100 %id)
AI935717 Kidney .a 3294 to 3833 541 to 1       541/541
(100 %)
6 diff
(98.9 %id)
AW589919 pooled germ cell tumors .a 3303 to 3620 318 to 1       318/318
(100 %)
0 diff
(100 %id)
AI252617 brain, tumor, 5 pooled (see description) .a 3307 to 3618 325 to 14   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 312/312
(100 %)
3 diff
(99.1 %id)
BM128478 Islets of Langerhans, Pancreas .a 3313 to 3836 524 to 1       524/524
(100 %)
0 diff
(100 %id)
CK819398 Islets of Langerhans, Pancreas .a 3329 to 3836 508 to 1       508/508
(100 %)
1 diff
(99.9 %id)
BM128893 Islets of Langerhans, Pancreas .a 3345 to 3836 492 to 1       492/492
(100 %)
0 diff
(100 %id)
AA977718 2 pooled tumors (clear cell type), Kidney .a 3349 to 3619 310 to 40   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 271/271
(100 %)
5 diff
(98.2 %id)
DB507311 testis .a 3357 to 3779 1 to 424     Submitted on the opposite strand 424/424
(100 %)
4 diff
(99.1 %id)
AI038558   .a 3364 to 3835 473 to 3       471/473
(99 %)
0 diff
(100 %id)
CB047319 Kidney .a 3379 to 3619 239 to 1   fully sequenced,   239/239
(100 %)
3 diff
(98.8 %id)
BI051787 placenta_normal .a 3386 to 3643 261 to 7       255/262
(97 %)
0 diff
(100 %id)
BM711197 eye, fetal eyes .a 3389 to 3752 364 to 1     Submitted on the opposite strand 364/364
(100 %)
2 diff
(99.5 %id)
BU737378 eye, fetal eyes .a 3389 to 3752 1 to 364     Submitted on the opposite strand 364/373
(97 %)
3 diff
(99.2 %id)
AI344281 colon, colon tumor, RER+ .a 3438 to 3620 184 to 2       183/184
(99 %)
0 diff
(100 %id)
AW450490   .a 3450 to 3833 401 to 18   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 384/392
(97 %)
0 diff
(100 %id)
AI633900 pooled germ cell tumors .a 3485 to 3835 351 to 1       351/351
(100 %)
2 diff
(99.5 %id)
AI650526 pooled germ cell tumors .a 3485 to 3835 351 to 1       351/351
(100 %)
0 diff
(100 %id)
AW235225 pooled germ cell tumors .a 3486 to 3835 350 to 1       350/350
(100 %)
0 diff
(100 %id)
AA781347   .a 3523 to 3841 323 to 6       318/323
(98 %)
0 diff
(100 %id)
AI758094 Kidney .a 3532 to 3835 308 to 3       306/308
(99 %)
0 diff
(100 %id)
BE550401 pooled germ cell tumors .a 3546 to 3835 290 to 1       290/290
(100 %)
0 diff
(100 %id)
BC026166 testis .b 1 to 3106 6 to 3111 P12S P16H tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 3106/3106
(100 %)
5 diff
(99.9 %id)
BC036113 testis .b 1 to 3106 1 to 3106 P12S P16H available from MGC, AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 3106/3106
(100 %)
5 diff
(99.9 %id)
TI_1948095052   .b 197 to 1130 126 to 1059       934/1305
(71 %)
32 diff
(97.6 %id)
TI_1948095215   .b 197 to 1123 126 to 1042       917/1243
(73 %)
25 diff
(98.0 %id)
TI_1948095372   .b 197 to 1132 128 to 1060       933/1254
(74 %)
33 diff
(97.4 %id)
TI_1948095053   .b 1125 to 2030 1033 to 131       900/1251
(71 %)
20 diff
(98.5 %id)
TI_1948094905   .b 1131 to 2030 1039 to 132       905/1284
(70 %)
13 diff
(99.0 %id)
TI_1948095373   .b 1196 to 2030 971 to 131       838/1322
(63 %)
24 diff
(98.2 %id)
TI_1948095216   .b 1298 to 2030 864 to 132       730/1314
(55 %)
2 diff
(99.9 %id)
AK094293 cerebellum .c 1 to 2481 2 to 2482 exact tiling clone, available from FLJ,   2482/2482
(100 %)
0 diff
(100 %id)
DA058505 cerebellum .c 1 to 555 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
BI561810 testis .c 97 to 651 1 to 556       556/819
(67 %)
23 diff
(97.2 %id)
TI_44350061   .c 102 to 651 126 to 676       551/939
(58 %)
22 diff
(97.7 %id)
DB484882 hypothalamus .c 126 to 469 1 to 361       320/392
(81 %)
24 diff
(93.9 %id)
DB506359 hypothalamus .c 126 to 592 1 to 468       466/476
(97 %)
7 diff
(98.6 %id)
DA275819 corpus callosum .c 132 to 694 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA864768 placenta .c 132 to 673 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
DA949837 Spleen .c 132 to 691 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
DB215493 trachea .c 132 to 613 2 to 483   capped   482/482
(100 %)
0 diff
(100 %id)
BQ954228 sciatic nerve .c 135 to 1045 1 to 918       916/929
(98 %)
26 diff
(97.3 %id)
DA489959 brain .c 138 to 707 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
BP872909 embryonal kidney .c 140 to 651 1 to 513       513/582
(88 %)
4 diff
(99.4 %id)
DA386729 thalamus .c 141 to 710 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
BE241716 leukopheresis .c 142 to 487 1 to 346       346/346
(100 %)
3 diff
(99.2 %id)
BQ717073 sympathetic trunk .c 146 to 863 12 to 731       720/845
(85 %)
8 diff
(99.1 %id)
CD692148 normal nasopharynx .c 149 to 738 17 to 606       590/606
(97 %)
0 diff
(100 %id)
DR004896 placenta .c 149 to 642 27 to 520       494/520
(95 %)
6 diff
(98.9 %id)
BG572376 placenta .c 151 to 876 1 to 723       723/761
(95 %)
5 diff
(99.4 %id)
DW466173 Liver .c 183 to 484 52 to 353       302/353
(85 %)
7 diff
(98.1 %id)
BG488694 large cell carcinoma, lung .c 197 to 878 1 to 705       705/718
(98 %)
37 diff
(94.9 %id)
CN390906 embryonic stem cells, cell lines H1, H7, andH9 .c 229 to 642 8 to 421       414/421
(98 %)
6 diff
(98.6 %id)
CV024654 mixed .c 298 to 941 1 to 644       644/644
(100 %)
6 diff
(99.1 %id)
BF513673   .c 309 to 595 308 to 21       288/310
(92 %)
7 diff
(97.8 %id)
AI904514 breast .c 327 to 658 31 to 362       332/663
(50 %)
8 diff
(98.8 %id)
BQ058789 lymph, lymphoma, cell line .c 464 to 1202 1 to 746       744/1064
(69 %)
19 diff
(98.3 %id)
BM561154 eye, retinoblastoma .c 517 to 1405 1 to 890       890/985
(90 %)
8 diff
(99.2 %id)
AW888579 nervous_tumor .c 641 to 956 7 to 320       314/321
(97 %)
23 diff
(92.9 %id)
BE799249 lung, small cell carcinoma .c 834 to 1390 34 to 621       562/684
(82 %)
31 diff
(95.5 %id)
BE791331 lung, small cell carcinoma .c 861 to 1700 1 to 838       838/887
(94 %)
18 diff
(98.0 %id)
BE886139 leiomyosarcoma, uterus .c 865 to 1405 1 to 558       558/816
(68 %)
35 diff
(95.8 %id)
BG106547 lymph, lymphoma, cell line .c 963 to 1663 1 to 702       702/1161
(60 %)
17 diff
(98.6 %id)
CF552075 Pooled muscle (cardiac and skeletal) .c 989 to 1842 28 to 882       855/882
(96 %)
17 diff
(98.1 %id)
BM150869 leukopheresis .c 1014 to 1362 1 to 349       349/349
(100 %)
15 diff
(95.8 %id)
CK327194 lung_tumor .c 1070 to 1595 1 to 526       526/530
(99 %)
7 diff
(98.7 %id)
CV397734 kidney_tumor .c 1107 to 1633 11 to 537       527/537
(98 %)
6 diff
(98.9 %id)
BQ328667 leiomios .c 1236 to 1814 12 to 595       584/595
(98 %)
35 diff
(94.2 %id)
BG878140 pnet .c 1247 to 1835 2 to 598       597/603
(99 %)
22 diff
(96.4 %id)
DB296793 cerebellum .c 1936 to 2481 546 to 1       546/552
(98 %)
0 diff
(100 %id)
TI_149288642   .c 2153 to 2844 774 to 85   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 690/691
(99 %)
3 diff
(99.6 %id)
CB242504 Human Lung Epithelial cells, lung .c 2174 to 2863 708 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 690/690
(100 %)
0 diff
(100 %id)
BM970470 lung .c 2175 to 2844 688 to 19   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 670/670
(100 %)
2 diff
(99.8 %id)
AW129650 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 2283 to 2771 492 to 4       489/492
(99 %)
0 diff
(100 %id)
DW467629 Liver .c 2407 to 2727 17 to 337       321/345
(93 %)
2 diff
(99.5 %id)
BE501572 malignant melanoma, metastatic to lymphnode, skin .c 2417 to 2770 354 to 1       354/354
(100 %)
0 diff
(100 %id)
BE501583 malignant melanoma, metastatic to lymphnode, skin .c 2417 to 2770 354 to 1       354/354
(100 %)
0 diff
(100 %id)
AF443854   .d 1 to 1039 1 to 1039   tiling clone, AAA   1039/1039
(100 %)
2 diff
(99.9 %id)
BX648325 uterus .d 8 to 3258 1 to 3250 C18R tiling clone, available from DKFZ,   3250/3250
(100 %)
6 diff
(99.9 %id)
BM699911 eye, lens .d 55 to 416 1 to 362   fully sequenced, Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 362/362
(100 %)
0 diff
(100 %id)
BX382985   .d 82 to 1130 1 to 1034   tiling clone,   1034/1034
(100 %)
18 diff
(98.3 %id)
BU623441 cell lines, Enchondroma .d 310 to 1029 726 to 7   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 720/726
(99 %)
0 diff
(100 %id)
BU737648 eye, lens .d 359 to 1050 699 to 8   tiling clone, fully sequenced, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 692/699
(98 %)
0 diff
(100 %id)
CA425610 cell lines, Chondrosarcoma .d 400 to 987 590 to 5   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 586/591
(99 %)
5 diff
(99.2 %id)
BF197247 pooled .d 540 to 1020 481 to 1       481/491
(97 %)
3 diff
(99.4 %id)
AI056068   .d 548 to 1021 474 to 1       474/474
(100 %)
1 diff
(99.8 %id)
AW629200 pooled .d 583 to 1023 441 to 1       441/441
(100 %)
0 diff
(100 %id)
AV751061 Pituitary .d 632 to 1017 80 to 457   AAA   378/457
(82 %)
8 diff
(98.3 %id)
AI394067 B-cell, chronic lymphotic leukemia .d 657 to 1040 384 to 2       383/384
(99 %)
0 diff
(100 %id)
EC530142 Prostate .d 2973 to 3068 1 to 93       93/93
(100 %)
2 diff
(97.9 %id)
AL834174 testis .e 1 to 4482 1 to 4486 G8M V9G L10V R11L I12R ... tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 4486/4486
(100 %)
2 diff
(100.0 %id)
FN153358 breast carcinoma .e 1106 to 1182 1 to 75       75/75
(100 %)
3 diff
(96.0 %id)
TI_149290257   .e 3710 to 4482 846 to 82   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 765/788
(97 %)
20 diff
(97.5 %id)
BX350865 Neuroblastoma Cot 25-normalized .e 3736 to 4460 731 to 1       731/838
(87 %)
20 diff
(97.7 %id)
BM973358 lung .e 3898 to 4482 604 to 19   AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 586/586
(100 %)
3 diff
(99.5 %id)
CR590558 T cells (Jurkat cell line) Cot10-normalized .f 1 to 1966 2 to 1967 exact tiling clone,   1967/1967
(100 %)
0 diff
(100 %id)
BX390598   .f 811 to 1736 1 to 921       921/921
(100 %)
10 diff
(99.0 %id)
BX373888   .f 1079 to 1960 898 to 5       894/902
(99 %)
0 diff
(100 %id)
AW834780 leiomios .f 1639 to 2019 1 to 381   tiling clone, AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 381/381
(100 %)
3 diff
(99.3 %id)
AK090419 Spleen .g 1 to 4332 1 to 4333 exact tiling clone, available from FLJ,   4333/4333
(100 %)
2 diff
(100.0 %id)
D78735 placenta .g 1655 to 1914 1 to 258       258/258
(100 %)
5 diff
(98.1 %id)
AL044909 testis .g 1738 to 2154 1 to 417       417/417
(100 %)
0 diff
(100 %id)
CA396505 eye, RPE/choroid .g 2224 to 2825 1 to 602       602/602
(100 %)
0 diff
(100 %id)
BG981280 colon_normal .g 2444 to 2584 3 to 144       142/144
(98 %)
6 diff
(95.9 %id)
BI916391 brain .g 2482 to 2880 1 to 401       401/479
(83 %)
4 diff
(99.2 %id)
TI_57239923   .g 2482 to 2880 74 to 474       401/552
(72 %)
4 diff
(99.3 %id)
CR999666 T-Lymphocytes .g 2855 to 3347 1 to 493   tiling clone,   493/493
(100 %)
0 diff
(100 %id)
DB007640 cervix, tumor tissue .h 1 to 569 2 to 570   tiling clone, capped   569/569
(100 %)
0 diff
(100 %id)
AW073313 brain, glioblastoma (pooled) .h 281 to 846 627 to 62   tiling clone,   566/632
(89 %)
7 diff
(98.9 %id)
BQ691707 ductal carcinoma, cell line, Pancreas .h 820 to 1399 1 to 580   tiling clone, AAA Possibly primed on the genome, locally A rich (29/31 A in genome downstream of last aligned base) 580/580
(100 %)
1 diff
(99.9 %id)
CN390907 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .i 1 to 660 1 to 660 exact tiling clone,   660/660
(100 %)
1 diff
(99.9 %id)
CA395612 eye, RPE/choroid .i 610 to 1244 1 to 635   tiling clone,   635/635
(100 %)
0 diff
(100 %id)
BJ997792 Wilms tumor .j-u 1 to 600 1 to 600   tiling clone,   600/600
(100 %)
0 diff
(100 %id)
F11851 brain, total brain .j-u 162 to 478 1 to 317   to resequence,   317/317
(100 %)
0 diff
(100 %id)
AA322523 brain, cerebellum .j-u 163 to 436 1 to 274       274/274
(100 %)
0 diff
(100 %id)
T65343 whole brain .j-u 163 to 558 1 to 403       403/413
(97 %)
11 diff
(97.4 %id)
AW955036   .j-u 170 to 609 1 to 434   tiling clone,   434/536
(80 %)
9 diff
(98.4 %id)
CR748267 B-cell, chronic lymphotic leukemia .j-u 844 to 1194 1 to 351   tiling clone,   351/351
(100 %)
0 diff
(100 %id)
AI056790 liver and spleen .j-u 1141 to 1616 476 to 1 exact tiling clone,   476/476
(100 %)
0 diff
(100 %id)
AW665509 pooled .j-u 1807 to 2374 566 to 1   tiling clone,   566/566
(100 %)
2 diff
(99.7 %id)
BX089275 whole brain .j-u 1873 to 2373 503 to 1   tiling clone,   503/503
(100 %)
2 diff
(99.7 %id)
AW379666 head_neck .j-u 1934 to 2222 1 to 287       287/288
(99 %)
28 diff
(90.3 %id)
AW379674 head_neck .j-u 1934 to 2222 1 to 287       287/288
(99 %)
28 diff
(90.3 %id)
AW379585 head_neck .j-u 1935 to 2222 14 to 302       289/303
(95 %)
12 diff
(96.1 %id)
T65150 whole brain .j-u 1935 to 2367 443 to 1       443/446
(99 %)
22 diff
(95.1 %id)
AW379576 head_neck .j-u 1937 to 2219 307 to 23       285/311
(91 %)
0 diff
(100 %id)
AW379662 head_neck .j-u 1937 to 2190 255 to 1       255/259
(98 %)
10 diff
(96.2 %id)
AW379670 head_neck .j-u 1937 to 2190 255 to 1       255/259
(98 %)
10 diff
(96.2 %id)
AW382163 head_neck .j-u 1937 to 2222 19 to 308       290/309
(93 %)
17 diff
(94.5 %id)
AW391382 stomach .j-u 1937 to 2218 288 to 2       287/292
(98 %)
0 diff
(100 %id)
AW391390 stomach .j-u 1937 to 2222 6 to 295       290/300
(96 %)
14 diff
(95.4 %id)
AW379661 head_neck .j-u 1946 to 2222 1 to 278       278/279
(99 %)
19 diff
(93.2 %id)
AW379669 head_neck .j-u 1946 to 2222 1 to 278       278/279
(99 %)
19 diff
(93.2 %id)
AW382514 head_neck .j-u 1946 to 2222 27 to 302       276/303
(91 %)
12 diff
(96.1 %id)
AW382515 head_neck .j-u 1946 to 2222 12 to 292       281/293
(95 %)
14 diff
(95.3 %id)
AW391380 stomach .j-u 1946 to 2222 21 to 299       279/300
(93 %)
13 diff
(95.7 %id)
AW382516 head_neck .j-u 1964 to 2222 2 to 258       257/259
(99 %)
14 diff
(94.6 %id)
AW391391 stomach .j-u 1965 to 2222 1 to 260       260/261
(99 %)
14 diff
(94.7 %id)
AW379660 head_neck .j-u 1975 to 2206 261 to 21       241/264
(91 %)
0 diff
(100 %id)
AW379668 head_neck .j-u 1975 to 2206 261 to 21       241/264
(91 %)
0 diff
(100 %id)
F09497 brain, total brain .j-u 2043 to 2359 317 to 1   to resequence,   317/317
(100 %)
0 diff
(100 %id)
AA846909 ovary .j-u 2052 to 2376 9 to 331   tiling clone,   323/337
(95 %)
4 diff
(98.9 %id)
AW877490 pnet .j-u 2100 to 2285 1 to 185       185/185
(100 %)
6 diff
(96.8 %id)
BQ071152 brain, neuroblastoma, cell line .k 1 to 834 1 to 840 exact tiling clone,   840/1024
(82 %)
15 diff
(98.6 %id)
DB027682 testis .l 1 to 491 2 to 492 exact tiling clone, capped   491/491
(100 %)
0 diff
(100 %id)
CR598716 Neuroblastoma Cot 25-normalized .m 1 to 923 1 to 923 exact tiling clone,   923/923
(100 %)
0 diff
(100 %id)
AL523925 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .m 6 to 886 1 to 879   fully sequenced,   879/879
(100 %)
19 diff
(97.9 %id)
BM479483 embryonal carcinoma, cell line, testis .m 27 to 881 1 to 870       870/1098
(79 %)
12 diff
(99.0 %id)
AL523924 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .m 576 to 897 315 to 1   fully sequenced,   315/315
(100 %)
9 diff
(97.2 %id)
AW501663 lymph .n-u 1 to 266 1 to 266       266/266
(100 %)
8 diff
(97.0 %id)
AW501720 lymph .n-u 1 to 251 1 to 251   tiling clone,   251/251
(100 %)
3 diff
(98.9 %id)
AW502122 lymph .n-u 1 to 444 1 to 444       444/444
(100 %)
3 diff
(99.4 %id)
AW502125 lymph .n-u 1 to 380 1 to 380       380/380
(100 %)
24 diff
(93.7 %id)
CF142499 lymph .n-u 1 to 462 1 to 462       462/462
(100 %)
3 diff
(99.4 %id)
CF142345 lymph .n-u 1 to 176 1 to 176       176/176
(100 %)
7 diff
(96.1 %id)
CF135301 lymph .n-u 1 to 478 1 to 478 S4I P52X     478/478
(100 %)
4 diff
(99.2 %id)
TI_154156739   .n-u 5 to 498 77 to 572 Q2H S4I P26S G45A S50I ...     496/518
(95 %)
36 diff
(93.1 %id)
TI_154156835   .n-u 5 to 518 77 to 587 L24F D56*     511/514
(99 %)
41 diff
(92.1 %id)
TI_154157436   .n-u 5 to 486 82 to 566 G92W L93A     485/489
(99 %)
6 diff
(98.8 %id)
TI_154163558   .n-u 5 to 857 70 to 909 S4I P52X     840/1178
(71 %)
48 diff
(96.0 %id)
TI_154173538   .n-u 5 to 615 77 to 687 exact     611/612
(99 %)
6 diff
(99.1 %id)
TI_154157484   .n-u 7 to 488 82 to 563 S4T K20R I27T Q32*     482/482
(100 %)
28 diff
(94.2 %id)
CN290443 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .n-u 176 to 775 10 to 609 exact tiling clone,   600/609
(98 %)
6 diff
(99.1 %id)
BG337191 leiomyosarcoma cell line, uterus .n-u 423 to 1131 1 to 702       702/945
(74 %)
11 diff
(98.9 %id)
BG339820 leiomyosarcoma cell line, uterus .n-u 423 to 1158 1 to 732       732/733
(99 %)
9 diff
(98.8 %id)
BG340027 leiomyosarcoma cell line, uterus .n-u 423 to 1104 1 to 680       680/681
(99 %)
5 diff
(99.3 %id)
BF115447 fibrotheoma, ovary .n-u 611 to 1028 418 to 1   tiling clone,   418/418
(100 %)
0 diff
(100 %id)
CR992190 T-Lymphocytes .n-u 811 to 1518 1 to 708   tiling clone,   708/708
(100 %)
0 diff
(100 %id)
BF942925 nervous_normal .n-u 812 to 1391 1 to 582       582/582
(100 %)
10 diff
(98.3 %id)
BF964643 muscle (skeletal) .o-u 581 to 690 589 to 698 C29V L30V L31M W32A L33G ... tiling clone,   654/700
(93 %)
25 diff
(96.5 %id)
AW664803 pooled .p 1 to 340 341 to 1 exact tiling clone,   341/341
(100 %)
4 diff
(98.9 %id)
BF929335 nervous_tumor .q-u 1 to 116 1 to 116 exact tiling clone,   116/118
(98 %)
2 diff
(98.4 %id)
AK295363 corpus callosum Gene DIS3L2, variant not shown         Suspected internal deletion, this clone was ignored    
CV395795 lung_tumor Gene DIS3L2, variant not shown         Suspected internal deletion, this clone was ignored    
BI462332 testis Gene DIS3L2, variant not shown         This clone was ignored    
DN998047 breast cancer, Mammary gland (cancer tissue) Gene DIS3L2, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j-u, .k, .l, .m, .n-u, .o-u, .p, .q-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI